Two Seattle-area startups were hand-picked by Bayer for a competitive program to create novel digital health solutions. It’s an endorsement of the region’s growing life science industry and of the potential for startups creating healthcare products with software and artificial intelligence.
Pear and Sandoz launched reSET, the first PDT authorized by FDA, in November last year. They won FDA clearance for reSET-O, for opioid use disorder, the following month.
Global Sunitinib Drug market Research Report includes data of the Top key industry players and their scope and share. The report offers types, investments, growth ratio, applications, manufacturers, opportunities, challenges. Future developments and latest contracts awarded in the market across different regions are demonstrated in the report.
On Wednesday the USA Stock Exchange company, Pfizer Inc., NYSE: PFE), the Trending-Graph. every buying and selling session display one-of-a-kind measures and patterns about, Drug Manufacturers – Major stock. Presently we observed the various factors that seen on close of last session. Toward the day’s end, it’s only a stock’s show that issues.
“Women in South Carolina and across the country were injured by the deceptive marketing of this product when they trusted that they were being helped,” Wilson said. “This settlement holds the companies accountable for violating state law and will prevent this deception from continuing.”
COLUMBIA — Attorney General Alan Wilson today announced a multistate settlement along with 40 states and the District of Columbia requiring Johnson & Johnson and its subsidiary Ethicon, Inc. to pay nearly $116.9 million for their deceptive marketing of transvaginal surgical mesh devices.
RALEIGH, N.C. (WNCT) Attorney General Josh Stein announced a $116.9 million multistate settlement with Johnson & Johnson and its subsidiary Ethicon Inc. over its deceptive marketing of transvaginal mesh devices.